N. Dezutter

Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.

Gordon Campbell, J. Findlay, P. Gallagher, 2006, Bioorganic & medicinal chemistry letters.

1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.

J. Findlay, J. Boot, J. Masters, 2005, Bioorganic & medicinal chemistry letters.

In vitro affinity of 99Tcm-labelled N2S2 conjugates of chrysamine G for amyloid deposits of systemic amyloidosis

G. Bormans, R. Sciot, T. D. de Groot, 2001, Nuclear medicine communications.

Evaluation of 99mTc-MAMA-chrysamine G as an in vivo probe for amyloidosis

P. Dupont, T. Groot, W. Landman, 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Characteristics and biological behaviour of 99mTc-labelled hydroxyacetyltriglycine, a potential alternative to 99mTc-MAG3

H. Vanbilloen, A. Verbruggen, N. Dezutter, 1997, European Journal of Nuclear Medicine.

Benzothienyloxy phenylpropanamines, novel dual inhibitors of serotonin and norepinephrine reuptake.

J. Findlay, P. Gallagher, S. Mitchell, 2004, Bioorganic & medicinal chemistry letters.

Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial

E. Kerwin, J. Tica, F. Struyf, 2022, The Journal of infectious diseases.

High-Throughput Screening of Excipients Intended to Prevent Antigen Aggregation at Air-Liquid Interface

Dominique Lemoine, Véronique Préat, Sébastien Dasnoy, 2011, Pharmaceutical Research.

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults.

M. Ison, J. Langley, L. Cámpora, 2023, The New England journal of medicine.

99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer’s disease

G. Bormans, R. Dom, T. D. de Groot, 1999, European Journal of Nuclear Medicine.

Preparation of 99mTc-N2S2 conjugates of chrysamine G, potential probes for the beta-amyloid protein of Alzheimer's disease

R. Busson, T. Groot, G. Janssen, 1999 .

The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains

Edison Ong, N. Dezutter, M. David, 2023, Science Translational Medicine.

119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated

E. Kerwin, J. Tica, N. Dezutter, 2020, Open Forum Infectious Diseases.

LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)

M. Ison, J. Langley, F. Martinón-Torres, 2022, Open Forum Infectious Diseases.